Evidence map›Paper›PMID 32114887›Full record

SynthesisJournal of the American Heart Association2020

Circulating Fatty Acids and Risk of Coronary Heart Disease and Stroke: Individual Participant Data Meta-Analysis in Up to 16 126 Participants.

Maria Carolina Borges, Amand Floriaan Schmidt, Barbara Jefferis, S Goya Wannamethee, Debbie A Lawlor, Mika Kivimaki, Meena Kumari, Tom R Gaunt, Yoav Ben-Shlomo, Therese Tillin and 9 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Journal of the American Heart Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. The Genetic Architecture of Multimodal Human Brain Age.bioRxiv : the preprint server for biology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 3 countries.

Maria Carolina BorgesMRC Integrative Epidemiology Unit at the University of Bristol United Kingdom.
Amand Floriaan SchmidtInstitute of Cardiovascular Science University College London London United Kingdom.
Barbara JefferisUCL Department of Primary Care & Population Health UCL Medical School London United Kingdom.
S Goya WannametheeUCL Department of Primary Care & Population Health UCL Medical School London United Kingdom.
Debbie A LawlorMRC Integrative Epidemiology Unit at the University of Bristol United Kingdom.
Mika KivimakiDepartment of Epidemiology and Public Health University College London London United Kingdom.
Meena KumariDepartment of Epidemiology and Public Health University College London London United Kingdom.
Tom R GauntMRC Integrative Epidemiology Unit at the University of Bristol United Kingdom.
Yoav Ben-ShlomoPopulation Health Sciences Bristol Medical School University of Bristol United Kingdom.
Therese TillinCardiometabolic Phenotyping Group Institute of Cardiovascular Science University College London London United Kingdom.
Usha MenonMRC Clinical Trials Unit at UCL Institute of Clinical Trials & MethodologyUniversity College London London United Kingdom.
Rui ProvidenciaFarr Institute of Health Informatics University College London London United Kingdom.
Caroline DaleFarr Institute of Health Informatics University College London London United Kingdom.
Aleksandra Gentry-MaharajMRC Clinical Trials Unit at UCL Institute of Clinical Trials & MethodologyUniversity College London London United Kingdom.
Alun HughesInstitute of Cardiovascular Science University College London London United Kingdom.
Nish ChaturvediInstitute of Cardiovascular Science University College London London United Kingdom.
Juan Pablo CasasMassachusetts Veterans Epidemiology Research and Information Center (MAVERIC) VA Boston Healthcare System Boston MA USA.
Aroon D HingoraniInstitute of Cardiovascular Science University College London London United Kingdom.
UCLEB Consortium**
University College London · GBUniversity of Bristol · GBFarr Institute · GBMRC Clinical Trials Unit at UCL · GBBarts Health NHS Trust · GBMRC Epidemiology Unit · GBUniversity of Essex · GBUniversity of Groningen · NLVA Boston Healthcare System · US

Funding

Socio-economic status and heterogeneity in agingR01AG013196 · NIA · UNIVERSITY OF LONDON INST OF NEUROLOGY · PI MARMOT, MICHAEL G, SINGH-MANOUX, ARCHANA · 1996 to 2013
$3.5M
Socioeconomic gradient in CHD in early old ageR01HL036310 · NHLBI · UNIVERSITY OF LONDON · PI KIVIMAKI, MIKA J, MARMOT, MICHAEL G · 1986 to 2012
$3.1M
British Heart Foundation CS/13/1/30327British Heart Foundation PG/13/66/30442British Heart Foundation PG/17/90/33415British Heart Foundation RG/07/008/23674British Heart Foundation RG/08/013/25942British Heart Foundation RG/10/12/28456British Heart Foundation RG/13/16/30528British Heart Foundation RG/19/4/34452British Heart Foundation SP/07/001/23603British Heart Foundation SP/13/6/30554Cancer Research UK C1479/A2884Department of Health NF‐SI‐0611‐10196Medical Research Council G0801228Medical Research Council G9901012Medical Research Council K013351Medical Research Council MC_UU_00011/4Medical Research Council MC_UU_00011/6Medical Research Council MC_UU_00019/2Medical Research Council MC_UU_12013/5Medical Research Council MC_UU_12013/8Medical Research Council MC_UU_12023/20Medical Research Council MR/P014054/1Medical Research Council MR/R024227/1Medical Research Council MR/S011676/1Medical Research Council MR_UU_12013/1NHLBI NIH HHS R01 HL036310NIA NIH HHS R01 AG013196Wellcome TrustWellcome Trust WT082464
6 · The paper itself

Abstract

Background We aimed at investigating the association of circulating fatty acids with coronary heart disease (CHD) and stroke risk. Methods and Results We conducted an individual-participant data meta-analysis of 5 UK-based cohorts and 1 matched case-control study. Fatty acids (ie, omega-3 docosahexaenoic acid, omega-6 linoleic acid, monounsaturated and saturated fatty acids) were measured at baseline using an automated high-throughput serum nuclear magnetic resonance metabolomics platform. Data from 3022 incident CHD cases (13 104 controls) and 1606 incident stroke cases (13 369 controls) were included. Logistic regression was used to model the relation between fatty acids and odds of CHD and stroke, adjusting for demographic and lifestyle variables only (ie, minimally adjusted model) or with further adjustment for other fatty acids (ie, fully adjusted model). Although circulating docosahexaenoic acid, but not linoleic acid, was related to lower CHD risk in the fully adjusted model (odds ratio, 0.85; 95% CI, 0.76-0.95 per standard unit of docosahexaenoic acid), there was evidence of high between-study heterogeneity and effect modification by study design. Stroke risk was consistently lower with increasing circulating linoleic acid (odds ratio for fully adjusted model, 0.82; 95% CI, 0.75-0.90). Circulating monounsaturated fatty acids were associated with higher CHD risk across all models and with stroke risk in the fully adjusted model (odds ratio, 1.22; 95% CI, 1.03-1.44). Saturated fatty acids were not related to increased CHD risk in the fully adjusted model (odds ratio, 0.94; 95% CI, 0.82-1.09), or stroke risk. Conclusions We found consistent evidence that linoleic acid was associated with decreased risk of stroke and that monounsaturated fatty acids were associated with increased risk of CHD. The different pattern between CHD and stroke in terms of fatty acids risk profile suggests future studies should be cautious about using composite events. Different study designs are needed to assess which, if any, of the associations observed is causal.

Indexed as

AdultAgedBiomarkersCase-Control StudiesCoronary Artery DiseaseFatty AcidsFemaleHeart Disease Risk FactorsHumansLinoleic AcidMaleMiddle AgedPrognosisProtective FactorsRisk AssessmentStrokeBiomarkersFatty AcidsLinoleic Acidcoronary artery diseaseepidemiologyfatty acidsstroke

Identifiers

PMID32114887
PMCPMC7335585
OpenAlexW3002524877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.